PT-141 (Bremelanotide) Research Peptide – UK Supplier
PT-141 (Bremelanotide) is a synthetic peptide studied in preclinical research for sexual response and neurological pathways. Maxx Labs supplies high-purity PT-141 with full UK batch documentation and COA verification.
Trust & Quality
🧪 Research Use Only • 🇬🇧 UK Supplier • 📄 COA Available • 🔬 ≥99% Purity • 🚚 Fast UK Dispatch
Chemical Information
• Synonyms: PT-141, Bremelanotide
• Form: Lyophilized powder, 10mg per vial
• Purity: ≥99%
• Storage: Store at 2–8°C, dry and shaded
Research Applications
• Neurological research on sexual response pathways
• Dopaminergic system studies
• Behavioural and receptor interaction models
Product Assurance
✅ HPLC Verified – ≥99% purity
✅ COA Provided – On Request
✅ GMP-Certified Facility – UK Dispatch
✅ Third-Party Verification Available
✅ Cold Chain Express Delivery
Storage & Handling
Store refrigerated at 2–8°C. Avoid repeated freeze-thaw cycles. Handle under lab conditions.
Related Products
• BPC-157
• Ipamorelin
• CJC-1295 (Without DAC)
⚠️ For Research Use Only
PT-141 is supplied strictly for scientific research purposes. Not for human or veterinary use.
⚠️ For Research Use Only – Not for Human Consumption
This product is intended strictly for laboratory research purposes and is not approved for human or veterinary use, therapeutic application, or diagnostic procedures. All handling must be performed by trained professionals in compliance with appropriate laboratory safety protocols and applicable regulations.
18+ Notice: This material is not for sale to individuals under the age of 18. By purchasing, you confirm that you are a qualified individual or acting on behalf of a qualified institution, and that the compound will be used exclusively for legitimate scientific investigation.
We acknowledge that in certain regions—particularly in countries outside of the United Kingdom, where manufacturing oversight and regulatory enforcement may be less stringent—there are isolated cases of individuals attempting to self-administer research compounds. We strongly discourage and explicitly warn against any such misuse. The self-experimentation of unapproved substances carries significant, unquantifiable risks and is both medically irresponsible and ethically unsound. Without proper analytical validation, GMP-level controls, and clinical context, the safety, quality, and pharmacological reliability of these materials cannot be assured.
All compounds must be handled in secure, controlled environments by competent personnel. Any deviation from these principles is contrary to responsible research practice and breaches both our terms of sale and the intended scientific use of these products.